CBD: +100 figures on the French and global cannabidiol market Discover the figures of the CBD market in France

France, European leader in hemp production

France is the leading hemp producer in Europe and the third in the world after China and Canada. In detail:

• France accounts for more than 60% of European hemp production;
• 1,713 tonnes of certified seed per year;
• 17,900 hectares of cultivated area, far ahead of Italy (4,000 hectares) and the Netherlands (3,833 hectares);
• 1,414 producers;
• 6 hemp beds;
• 70% of French hemp production is exported.

Source: Hemp Interprofession.

The enthusiasm of French consumers for CBD products

Since the historic decision of the Court of Justice of the European Union (CJEU) at the end of 2020, the French CBD market has developed rapidly:

• According to figures from the Interprofession des métiers du hemp relayed by the very serious media LSA Conso, France has nearly7 million regular or occasional consumers of products containing CBD or other non-psychotropic cannabinoids. This is about 11% of the French population... a proportion that remains below the European average estimated at 16%;
• 70% of French consumers of CBD products are men;
• 69% of French adults have already heard of CBD products (end of 2021), and 10% report having already used it (source);
• Around 3.3% of French adults consume CBD products several times a week (source);
• An Ifop study gives a higher proportion, explaining that 26% of French adults have already consumed CBD products or other cannabinoids (2022);
• Despite legal uncertainty, the offer continues to structure and develop. The year 2021 saw the opening of more than 2,000 stores specializing in legal hemp products, a dazzling increase of + 500% in one year. This count does not include tobacconists, parapharmacies, supermarkets, supermarkets, shops specializing in vaping products, etc;
• CBD flowers and leaves account for between 60 and 80% of the industry's overall turnover. This is what prompted professionals to protest after an ephemeral decision by the government to ban the marketing of pure CBD leaves and flowers in France;
• The French CBD market is estimated at 1 billion euros (2022), but it should exceed 2.5 billion euros by 2025. If the major study carried out by the government on the therapeutic applications of hemp leads to positive conclusions, this figure should be (largely) revised upwards.

What motivates CBD users?

A UK study attempted to shed light on the main reasons why lead to the consumption of cannabidiol and cannabinoid products:

• Neutralizing anxiety comes first, with 42.6% of CBD users surveyed;
• The improvement of the quality of sleep, in particular by combating insomnia and REM sleep disorders (nocturnal verbalization, awakenings in the middle of the night, muscle spasms, etc.) comes in second place, with 42.5% of consumers surveyed;
• Stress reliefs ranks third (37%);
• Improved general health and well-being ranks fourth (37%).

An American study probed the motivations of American consumers of CBD products. Summary of results:

• Relieve stress and anxiety (49%);
• Improve the quality of sleep and fight against insomnia (42%);
• Relieve joint pain and arthritis (27%);
• Fighting depression and mood disorders (26%);
• Relieve migraines and headaches (21%);
• Recreational use, without psychotropic effect (12%);
• Improve pet welfare (8%);
• Alleviate certain mental disorders (8%);
• Relieve digestive symptoms (8%);
• Topical use to treat inflammatory skin conditions (acne, psoriasis, eczema) or simply to take care of your skin (6%);
• To improve general well-being (5%);
• Other (2%).

What about the perceived effectiveness of CBD products?

A study that surveyed 4,000 US consumers attempted to quantify the effectiveness of CBD in reducing stress, soothing joint pain, and improving sleep. Summary of results:

• About 75% of US consumers surveyed believe that CBD is at least moderately effective in treating these symptoms;
• About half of US consumers surveyed believe that CBD is "very" or "extremely" effective in treating these symptoms;
• 63% of consumers believe that cannabidiol is effective in relieving stress and anxiety;
• 52% of consumers surveyed say that CBD is effective in improving the quality and quantity of sleep;
• 38% agree that cannabidiol is effective in relieving joint pain.

A study has shown that among French consumers of cbd products of CBD, 32.4% are cannabis users. “CBD would counteract certain consequences of cannabis use, including anxiety or paranoia,” the study reads.

CBD and our pets

Pets also have an endocannabinoid system. They can therefore theoretically benefit from the analgesic, anti-inflammatory and soothing effects of CBD products.

The following numbers concern the United States, insofar as no French (or European) study has been carried out at the time of writing:

• In the United States, 24% of pet owners use CBD products for themselves or their pet;
• CBD products for pets generated $560 million in sales in the US market in 2021;
• 74% of CBD users in the United States have at least one pet;
• CBD products for pets will account for approximately 5% of CBD oil sales by 2025 in the US market.

CBD, a (very) profitable molecule

• It is estimated that an online CBD store generates a net margin of between 15 and 35%, or a net profit of between €15,000 and €35,000 for €100,000 of sales figures. 'business;
• The average yield per hectare of hemp is estimated at €2,500, i.e. 8 times more than a hectare of wheat.

Maximum THC level: France remains on a cautious ceiling

THC (tetrahydrocannabinol) is the main psychotropic molecule of the hemp plant. Put simply, it is the substance responsible for the "high" effect of cannabis. Countries that have legalized CBD consumption have all implemented maximum THC levels in cannabinoid-containing products:

• Like the majority of EU countries, France has adopted a conservative position, with a THC level of less than 0.3% (0.2% before 2022), guaranteeing the absence of any psychotropic effect in CBD products marketed;
• Italy was less conservative, with a maximum THC level set at 0.5%;
• Switzerland is the most "tolerant" country towards THC, with a maximum rate of 1%;
• The United States is aligned with the European cap, with a limit of 0.3% THC.

The global market for CBD products

The statistics on the global market for CBD products should be taken with a grain of salt, insofar as studies give very variable figures, with differences that can reach 300% from one organization to another. The fact that the CBD market is not necessarily well regulated everywhere is probably not unrelated to this problem of precision.

According to Grand View Research, the global market size for cannabidiol-cbd products cannabidiol (CBD) and other non-psychotropic cannabinoids (CBG, CBN, CBC…) is valued at $5.18 billion in 2021. According to another study by Global Market Insight, the market global CBD would rather be estimated at 15 billion euros in 2022.

• According to Grand View Research, the global CBD market is expected to grow at a compound annual growth rate (CAGR) of 16.8% between 2022 and 2030. Based on the study by Global Market Insight, the annual growth of the CBD market would rather be around 20% per year from 2021 to 2028;
• According to a Pont Europe study, the European CBD market would be worth around 2.2 billion euros in 2022, with a compound annual growth rate of 20% between 2021 and 2028;
• The Business to Business (B2B) segment dominates the global CBD market, generating 59% of revenue in 2020;
• In the United States, the CBD market is expected to reach $25 billion by 2025 (source);
• According to Forbes Health, the most consumed CBD products in the United States are cannabidiol edibles (58%), CBD capsules and oils (55%), CBD (53%), creams and other topical products (42%), vaping products (32%), CBD flowers (16%) and other unusual products (2%);
• One in 7 Americans consume cannabidiol (or other non-THC cannabinoids) daily (source);
• The proportion of consumers of CBD products in the US population is expected to increase from 6% in 2018 to 35% in 2024;
• In the United States, 72% of CBD consumers are men;
• CBD is consumed by 20% of Americans aged 18-29, 16% in the 30-49 age group, 11% in the 50-64 age group, and 8% in those over 64.< /li>

The pharmaceutical sector is particularly represented in B2B demand. The needs of the pharmaceutical industry for cannabidiol (CBD) and cannabinoids are expected to grow by several points between 2022 and 2030 for several reasons:

• Multiplication of ongoing clinical trials to confirm (or invalidate) the soothing, analgesic, anti-inflammatory and antioxidant effects of CBD;
• Rapidly evolving techniques for processing CBD at lower cost;
• Enthusiasm of alternative and/or alternative medicine professionals for CBD-based products.

Source: Grand View Research

CBD and legal hemp are driving the web crazy!

• The number of queries around cannabidiol has increased by more than 400% between 2015 and 2021 (Google Trends);
• A historic peak of requests around CBD was reached at the beginning of January 2022. This peak is explained by the publication of the famous government decree prohibiting the marketing of raw CBD leaves and flowers, then by the temporary lifting of this ban by the Council of State three weeks later;
• Today, the term "CBD" is entered 78,000 times per month on Google.fr;
• According to a study by Brightfield Group, 40% of sales of CBD and legal hemp products are done online in the United States. No similar study has been carried out in France.

In France, CBD has made an incursion into supermarkets

In addition to online stores, which remain the preferred supplier for aficionados of the molecule thanks to a very wide choice, CBD products are available in pharmacies and parapharmacies, delicatessens, tobacconists and malls. At the start of 2022, Monoprix circulated a "CBD Truck" in the Paris region to promote its "CBD" section, which was opened in 250 urban stores throughout France.

CBD and side effects

Although CBD is generally very well tolerated by the body, some mild and temporary side effects may occur. In a US study, about 33% of CBD users reported mild side effects such as dry mouth, appetite stimulation, fatigue, and mild eye irritation.

CBD: the consumption habits of the French in a few key figures

As a key player in the French CBD market and, more broadly, non-psychotropic cannabinoids and legal hemp, our online store is able to give you statistics that are relatively representative of French consumption habits.

#1 The average basket

The average basket represents the average amount of an order on the CBD market. To calculate it, simply divide the cumulative turnover by the number of orders over the year. Thus, the average basket is €62.74.

#2 The ranking of the products most purchased by CBD consumers

Unsurprisingly, CBD flowers topped the list of the most popular cannabidiol products, despite the legal hubbub that almost led to a ban on the marketing of raw CBD flowers and leaves in France. , before the intervention of the Council of State.

In detail, here is a summary table which ranks the best-selling products in France, with the percentage of all sales and the average price of the category.

As you can see, CBD flowers are the most popular with CBD consumers. It must be said that this format has the good points:

• CBD flowers are appreciated by purists who are passionate about the history of strains and varieties, crosses, etc;
• CBD flowers are versatile, insofar as they can be consumed in an infusion or a decoction, be inhaled using a suitable vaporizer, season everyday dishes, etc;
• CBD flowers cover all concentrations, from mild flower to ultra-potent flower;
• Consumers have the choice between CBD flowers grown indoors (Indoor), outdoors (Outdoor) or in greenhouses (Greenhouse), each mode of cultivation having its advantages and disadvantages.

#3 What are the most represented age groups?

CBD products are prohibited for minors, and we make it a point of honor to verify the age of consumers before validating an order. As you will see, CBD products are consumed by all ages, from 18 to over 60:

• 18 – 24 years old: 10.3%;
• 25 – 34 years old: 29.4%;
• 35 – 49 years old: 28.5%;
• 50 – 59 years: 0.05%;
• 60 and over: 25.7%.

#4 What is the average price of CBD flowers in B2C?

The average price per gram of cannabidiol flowers in the B2C market is between 3 and 15€ depending on the concentration and the strain.

#5 What are the prices of CBD products in B2B (wholesale)?

The "wholesale" prices for CBD flowers vary widely depending on the strain, the concentration and the method of cultivation (Indoor, Outdoor or Greenhouse).

Here are some examples:

• Pop Corn Outdoor flowers: €0.45 per gram for a quantity of 1,000 g;
• OG Kush Greenhouse flowers: €0.85 per gram for a quantity of 1000g;
• Flower Amnesia Indoor: €2.30 per gram for a quantity of 1,000 g.

The "crumble", "crystal", and "asteroid" type formats are more expensive as they are ultra-concentrated:

• Moonrock flowers 70%: €3.20 per gram for a quantity of 1,000 g;
• Crumble CBD 92.9%: €3.30 per gram for a quantity of 1,000 g;
• Crystal CBD 99.9%: €3.00 per gram for a quantity of 1,000 g.